Sajjadi et al (New Biol., 3?769-778, 1991.* |
Burgess et al (J. Cell Bio., 111:2129-2138, 1990.* |
Lazar et al (Mol and Cell Bio., 8:1247-1252), 1988.* |
Tao et al (J. Immunol., 143:2595-2601), 1989.* |
Maisonpierre et al Oncogene (1993) 8:3227-3288.* |
Johnstone & Thorpe—Immunochemistry in Practice Blackwell Scientific Publications, 1987 p 30.* |
Aaronson, “Growth Factors and Cancer,” Science 254:1146-1153 (1991). |
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/Ca2+ Signal Transduction,” J. Biol. Chem. 267:13361-13368 (1992). |
Adelman et al., “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone, ” DNA 2(3):183-193 (1983). |
Basler and Hafen, “Ubiquitous Expression of sevenless: Position-Dependent Specification of Cell Fate,” Science 243:931-934 1989. |
Benoist and Chambon, “In vivo sequence requirements of the SV40 early promoter region,” Nature 290:304-310 (1981). |
Bird et al., “Single-Chain Antigen-Binding Proteins,” Science 242:423-426 (1988). |
Bitter et al., “Expression and Secretion Vectors for Yeast,” Methods in Enzym. 153:516-544 (1987). |
Böhme et al., “PCR mediated detection of a new human receptor-tyrosine-kinase, HEK 2,” Oncogene 3:2857-2862 (1993). |
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs,” Proc. Natl. Acad. Sci. USA 82:4438-4442 (1985). |
Capecchi, “Altering the Gonome by Homologous Recombination,” Science 244:1288-1292 (1989). |
Chabot et al., “The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W location,” Nature 335:88-89 (1988). |
Chan and Watt “eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases,” Oncogene 6:1057-1061 (1991). |
Chen and Okayama, “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA,” Mol. and Cell. Biol. 7(8):2745-2752 (1987). |
Chomczynski and Sacchi, “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,” Analytical Biochemistry 162:156-159 (1987). |
Chowdhury et al., “Long-term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits,” Science 254:1802-1805 (1991). |
Ciossek et al., “Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system,” Oncogene 10(1):97-108 (1995). |
Colbére-Garapin et al., “A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells,” J. Mol. Biol. 150:1-14 (1981). |
Cole et al., “The EBV-Hybridoma Technique and its Application to Human Lung Cancer,” pp. 77-96 in Monoclonal Antibodies and Cancer Therapy eds. Reisfeld and Sell, Alan R. Liss, Inc., New York (1985). |
Creighton, Proteins: Structures and Molecular Principles pp. 79-86, W.H. Freeman and Co., New York, (1983). |
Cristiano et al., “Hepatic Gene Therapy: Adenovirus Enhancement of Receptor-Mediated Gene Delivery and Expression in Primary Hepatocytes,” Proc. Natl. Acad. Sci. USA 90:2122-2126 (1993). |
Curiel et al., “Adenovirus Enhancement of Transerrin-polylysine-mediated Gene Delivery,” Proc. Natl. Acad. Sci. USA 88:8850-8854 (1991). |
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway,” Am. J. Respir. Cell. Mol. Biol. 6:247-252 (1992). |
Domchek et al., “Inhibition of SH2 Domain/Phosphoprotein Association by a Nonhydrolyzable Phosphonopeptide,” Biochemistry 31:9865-9870 (1992). |
Ellis et al., “Embryo Brain Kinase: a novel gene of the eph/elk receptor XP002002321 tyrosine kinase family,” EMBL Database entry MMBEK, Accession No. X81466, Sep. 16, 1994). |
Fantl et al., “Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways,” Cell 69:413-423 (1992). |
Feinberg and Vogelstein, “A Techique for Radiolabeling DNA Restriction Endonuclease Fragments to High Specific Activity,” Analytical Biochemistry 132:6-13 (1983). |
Felder et al., “SH2 Domains Exhibit High-Affinity Binding to Tyrosine-Phosphorylated Peptides Yet Also Exhibit Rapid Dissociation and Exchange,” Mol. and Cell. Biol. 13(3):1449-1455 (1993). |
Felgner and Ringold, “Cationic liposome-mediated transfection,” Nature 337:387-388 (1989). |
Felgner et al., “Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure,” Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987). |
Fendly et al., “Characterization of Murine Monoclonal Antibodies Reactive to Either the Human or Epidermal Growth Factor Receptor or HER2/neu Gene Product” Cancer Research 50:1550-1558 (1990). |
Fingl and Woodbury, Chapter 1, pp. 1-46 in The Pharmacological Basis of Therapeutics (5th edition),eds. Goodman et al., MacMillan Publishing Co., Inc., New York (1975). |
Fry et al., “New insights into protein-tyrosine kinase receptor signaling complexes,” Protein Science 2:1785-1797 (1993). |
Geissler et al., “The Dominant-White Spotting (W) Locus of the Mouse Encodes the c-kit Proto-Oncogene,” Cell 55:185-192 (1988). |
Gilardi-Hebenstreit et al., “An Eph-related receptor protein tyrosine kinase gene segmentally expressed in the developing mouse hindbrain,” Oncogene 7:2499-2506 (1992). |
Hamer and Walling, “Regulation in vivo of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors,” J. of Molecular and Applied Genetics 1:273-288 (1982). |
Hammer et al., “Spontaneous Inflammatory Disease in Transgenic Rats Expressing HLA-B27 and Human β2m: An Animal Model of HLA-B27-Associated Human Disorders,” Cell 63:1099-1112 (1990). |
Hanks et al., “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains,” Science 241:42-52 (Jul. 1988). |
Hardie, “Roles of Protein Kinases and Phosphatases in Signal Transduction,” Symp. Soc. Exp. Bio. 44:241-255 (1990). |
Hirai et al., “A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene,” Science 238:1717-1720 (1987). |
Houdebine and Chourrout, “Transgenesis in Fish,” Experientia 47:891-897 (1991). |
Huston et al., “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli,” Proc. Natl. Acad. Sci. USA 85:5879-5883 (1988). |
Inouye and Inouye, “Up-promotor mutations in the lpp gene of Escherichia coli,” Nucleic Acids Research 13(9):3100-3111 (1985). |
Jansen et al., “Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity,” Immunological Rev. 62:185-216 (1982). |
Johnston and Hopper, “Isolation of the yeast regulatory gene GAL4 and analysis of its dosage effects on the galactose/melibiose regulon,” Proc. Natl. Acad. Sci. USA 79:6971-6975 (1982). |
Joyner et al., “Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells,” Nature 338:153-156 (1989). |
Kaneda et al., “The Improved Efficient Method for Introducing Macromolecules into Cells Using HVJ (Sendai Virus) Lipsomes with Gangliosides,” Experimental Cell Research 173:56-69 (1987). |
Kaneda et al., “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver,” Science 243:375-378 (1989). |
Killen and Lindstrom, “Specific Killing of Lymphocytes that Cause Experimental Autoimmune Myasthenia Gravis by Ricin Toxin-Acetylcholine Receptor Conjugates,” J. of Immunology 133:2549-2553 (1984). |
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature 256:495-496 (1975). |
Kozak, “Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs,” Nucleic Acids Research 12:857-873 (1984). |
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes,” Immun. Today 4(3):72-79 (1983). |
Lam et al., “A new type of synthetic peptide library for identifying ligand-binding activity,” Nature 354:82-84 (1991). |
Lammers, “Differential Activities of Proteins Tyrosine Phosphatases in Intact Cells,” J. Biol. Chem. 268:22456-22462 (1993). |
Letwin et al., “Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody,” Oncogene 3:621-627 (1988). |
Lindberg and Hunter, “cDNA Cloning and Characterization of eck, an Epithelial Cell Receptor Protein-Tyrosine Kinase in the eph/elk Family of Protein Kinases,” Mol. and Cell. Biol. 10:6316-6324 (1990). |
Logan and Shenk, “Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection,” Proc. Natl. Acad. Sci. USA 81:3655-3659 (1984). |
Lowy et al., “Isolation of Transforming DNA: Cloning the Hamster aprt Gene,” Cell 22:817-823 (1980). |
Maher, “Tissue-dependent Regulation of Protein Tyrosine Kinase Activity during Embryonic Development,” J. Cell. Biol. 112:955-963 (1991). |
Maisonpierre et al., “Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression,” Oncogene 8:3277-3288 (1993). |
Marasco et al., “Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp 120 single-chain antibody,” Proc. Natl. Acad. Sci. USA 90:7889-7893 (1993). |
McKnight, “Functional Relationships between Transcriptional Control Signals of the Thymidine Kinase Gene of Herpes Simplex Virus,” Cell 31:355-365 (1982). |
Millauer, “High Affinity VEGF Binding and Developmental Expression Suggest Flk-1 as a Major Regulator of Vasculogenesis and Angiogenesis,” Cell 72:835-846 (1993). |
Morrison et al., “Chimeric human antibodymolecules: Mouse antigen-binding domains with human constant region domains,” Proc. Natl. Acad. Sci. USA 81:6851-6855 (1984). |
Mulligan and Berg, “Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyeltransferase,” Pro. Natl. Acad. Sci. USA 78(4):2072-2076 (1981). |
Mulligan, “The Basic Science of Gene Therapy,” Science 260:926-932 (1993). |
Nelson et al., “Detection of Acridinium Esters by Chemiluminescence,” Nonisotopic DNA Probe Techniques ed. L.J. Kricka (San Diego:Academic Press, Inc. pp. 275-310 (1992). |
Neuberger et al., “Recombinant antibodies possessing novel effector functions,” Nature 312:604-608 (1984). |
Nieto et al., “A receptor protein tyrosine kinase implicated in the segmental patterning of the hindbrain and mesoderm,” Development 116:1137-1150 (1992). |
Nocka et al., “Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice—evidence for an impaired c-kit kinase in mutant mice,” Genes Dev. 3:816-826 (1989). |
O'Hare et al., “Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrfolate reductase,” Proc. Natl. Acad. Sci. USA 78(3):1527-1531 (1981). |
Pasquale, “Identification of chicken embryo kinase 5, a developmentally regulated receptor-type tyrosine kinase of the Eph family,” Cell Regulation 2:523-534 (1991). |
Pasquale et al., “Cek5, a Membrane Receptor-Type Tyrosine Kinase, Is in Neurons of the Embryonic and Postnatal Avian Brain,” J. Neuroscience 12:3956-3967 (1992). |
Pasquale and Singer, “Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library,” Proc. Natl. Acad. Sci. USA 88:5449-5453 (1989). |
Posada and Cooper, “Molecular Signal Integration. Interplay Between Serine, threonine and Tyrosine Phosphorylation,” Mol. Biol. of the Cell 3:583-592 (1992). |
Pursel et al., “Genetic Engineering of Livestock,” Science 244:1281-1288 (1989). |
Raffioni et al., “The Receptors for Nerve Growth Factor and Other Neurotrophins,” Annu. Rev. Biochem. 62:823-850 (1993). |
Redemann et al., “Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants,” Mol. and Cell. Biol. 12(2):491-498 (1992). |
Rotin et al., “SH2 domains prevent tyrosin dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cy,” The EMBO J. 11(2):559-567 (1992). |
Rüther and Müller-Hill, “Easy identification of cDNA clones,” EMBO J. 1791-1794 (1983). |
Sajjadi and Pasquale, “Five novel avian Eph-related tyrosine kinases are differentially expressed,” Oncogene 8:1807-1813 (1993). |
Sanger et al., “DNA sequencing with chain-terminating inhibitors,” Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977). |
Santerre et al., “Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells,” Gene 30:147-156 (1984). |
Schlessinger, “Signal transduction by allosteric receptor oligomerization,” Trends Biochem. Sci. 13:443-447 (1988). |
Silver et al., “Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization,” Proc. Natl. Acad. Sci. USA 81:5951-5955 (1984). |
Skolnik et al., “Cloning of P13 Kinase-Associated p85 Utilizing a Novel Method for Expression/Cloning of Target Proteins for Receptor Tyrosin Kinases,” Cell 65:83-90 (1991). |
Songyang et al., “SH2 Domains Recognize Specific Phosphopeptide Sequences,” Cell 72:767-778 (1993). |
Sprenger et al., “The Drosophila gene torso encodes a putative receptor tyrosine kinase,” Nature 338:478-483 (1989). |
Stephenson et al., “Platelet-derived growth factor receptor α-subunit gene (Pdgrfa) is deleted in he mouse patch (Ph) mutation,” Proc. Natl. Acad. Sci. USA 88:6-10 (1991). |
Stryer, Lubert, Biochemistry (Third Edition) W. H. Freeman & Company, New York, pp. 7-8 (1988). |
Szybalska and Szybalski, “Genetics of Human Cell Lines, IV. DNA-Mediated Heritable Transformation of a Biochemical Trait,” Proc. Natl. Acad. Sci. USA 48:20262034 (1962). |
Takeda et al., “Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences,” Nature 314:452-454 (1985). |
Ullrich and Schlessinger, “Signal Transduction by Receptors with Tyrosine Kinase Activity,” Cell 61:203-212 (1990). |
Van Heeke and Schuster, “Expression of Human Asparagine Synthetase in Escherichia coli,” J. Biol. Chem. 264(10)5503-5509 (1989). |
Ward et al., “Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli,” Nature 341:544-546 (1989). |
Wicks et al, “Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human Lymphoid tumor cell lines”, Proc. Natl. Acad. Sci. USA 89:1611-1615 (1992). |
Wigler et al, “Transformation of mammalian cells with an amplifiable dominant-acting gene”, Proc. Natl. Acad. Sci. USA 77(6):3567-3570 (1980). |
Wigler et al, “Transfer of Purified Herpes Virus Thymidine Kinase Gene to Cultured Mouse Cells”, Cell 11:223-232 (1977). |
Wilson et al, “Clinical Protocol: Ex Vivo Gene Therapy of Familial Hypercholesterolemia”, Human Cell Therapy 3:179-222 (1991). |
Wolff et al., “Direct Gene Transfer into Mouse Muscle In Vivo” Science 247:1465-1468 (1990). |
Wu and Wu, :Receptor-mediated in Vitro Gene Transformation by a Soluble DNA Carrier System, J. Biol. Chem. 262:4429-4432 (1987). |
Wu et al, “Characterization and Molecular Cloning of a Putative Binding Protein for Heparin-binding Growth Factors”, J. Biol. Chem. 266:16778-16785 (1991). |
Yang et al, “In Vivo and In Vitro Gene Transfer to Mammalian Somatic Cells by particle Bombardment”, Proc. Natl. Acad. Sci. USA 87:9568-9572 (1990). |
Zhu et al, “Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice”, Science 261:209-211 (1993). |
P. Bork, “Powers and pitfalls in sequence analysis: the 70% Hurdle”, Genome Research 10:398-400 (2000) Cold Spring Harbor Laboratory Press. |
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science 247:1268-1310 (1990) American Assoc. for the Advancement of Science. |
Computer Search Results, Sequence Listings: Accession Nos. Q34513, T02947, T02948 (related to W0 93/00425), May 24, 1993, 5 pages. |